Germany's Discount Contracts Are Changing The Pharma Market Landscape
This article was originally published in The Pink Sheet Daily
Executive Summary
Regional firm wins an important tender, but at a discount that is so steep it attacks the process as creating "only losers."
You may also be interested in...
Germany’s New Non-Substitution Drug List No Big Bang For Pharma
Germany will have its first list of non-substitutable pharmaceuticals since the introduction of discount contracts, but the benefit it offers to original product manufacturers will be severely limited.
Germany’s Grand Coalition Offers Pharma Little Certainty, Except For Continued Discounts
Germany’s new grand coalition government includes a health minister with no background in health care.
EU Pricing Pressures On Generics And Biosimilars Risk Killing Industry –EGA Execs
New EGA president and director general say Europe must end downward pricing pressures on generic medicines manufacturers or risk losing that industry altogether.